Ajanta Pharma submits disclosures

29 Nov 2021 Evaluate

Ajanta Pharma has informed that the Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 29, 2021 for Aayush M Agrawal, Trustee Aayush Agrawal Trust.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

2789.50 -10.90 (-0.39%)
24-Mar-2026 11:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1758.15
Dr. Reddys Lab 1256.35
Cipla 1221.00
Zydus Lifesciences 868.60
Lupin 2291.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×